Cargando…
Evaluation of the paediatric dose of chloroquine in the treatment of Plasmodium vivax malaria
BACKGROUND: Chloroquine (CQ) continues to be the first-line medication used worldwide in the treatment of Plasmodium vivax malaria. The dose recommended by the World Health Organization is 25 mg/kg independently of the age of the subject. Nonetheless, the pharmacokinetics and pharmacodynamics of dru...
Autores principales: | Añez, Arletta, Moscoso, Manuel, Garnica, Cecilia, Ascaso, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950695/ https://www.ncbi.nlm.nih.gov/pubmed/27430284 http://dx.doi.org/10.1186/s12936-016-1420-5 |
Ejemplares similares
-
Resistance of infection by Plasmodium vivax to chloroquine in Bolivia
por: Añez, Arletta, et al.
Publicado: (2015) -
Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia
por: Getachew, Sisay, et al.
Publicado: (2015) -
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018) -
Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia
por: Teka, Hiwot, et al.
Publicado: (2008) -
The effect of SNPs in CYP450 in chloroquine/primaquine Plasmodium vivax malaria treatment
por: Sortica, Vinicius A, et al.
Publicado: (2016)